Merck KGaA - Company Profile
Powered by 
All the data and insights you need on Merck KGaA in one report.
$295
- Save hours of research time and resources with
our up-to-date Merck KGaA Strategy Report
- Understand Merck KGaA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBusiness Description
Merck KGaA (Merck), a subsidiary of E. Merck KG, develops, manufactures, and markets prescription drugs and specialty chemical products. In the US and Canada, the company operates as EMD Serono in the Biopharma business; as MilliporeSigma in the Life Science business; and as EMD Performance Materials in the Materials business.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The core areas of Merck’s research include immunology, cancer, and immuno-oncology, besides diagnosing and treating allergies. In the Life Science business sector, it focuses research on technologies for laboratory and life science applications. It focuses on digital and automated laboratory equipment, the future factory, innovative approaches, and offering more eco-friendly products for labs. The company aims at making a beneficial impact on patients through its R&D pipeline in the Healthcare sector. Its primary research areas encompass oncology and immunology with specific focus on multiple sclerosis. In the Electronics sector, the main research thrust is on creating innovative materials and technologies essential for producing increasingly compact, faster, more potent, and sustainable processors and memory chips. The Electronics division pioneers new materials for future displays and develops functional and decorative effect pigments used in the automotive, cosmetics, and other industrial sectors. The company established its R&D hubs strategically on three continents, namely, North America, Europe, and Asia-Pacific. It operates R&D centers in the UK, Taiwan, South Korea, North America, Germany, Japan, Israel, China, France, and Taiwan. In FY2023, the company’s R&D expenses amounted to EUR2,438 million, which as a percentage of revenue, stood at 11.6%. The company obtained numerous domestic and foreign patents covering pharmaceutical and other products and their uses, product manufacturing processes and pharmaceutical formulations.
Business Segments
Overview
Offers high-tech chemicals for applications in consumer electronics, coatings, lighting, printing technology, plastics, paints and cosmetics. It conducts business through three categories, Semiconductor Solutions, Display Solutions and Surface Solutions. The Semiconductor Solutions consists of two divisions, namely, Semiconductor Materials and Delivery Systems & Services (DS&S). Semiconductor materials unit supplies products for wafer manufacturing process; specialty cleaners and conductive pastes for semiconductor packaging. DS&S division develops delivery equipment. The Display Solutions business unit offers liquid crystals, OLED, photoresists and liquid crystal windows. The Surface solutions business develops and markets decorative effect pigments and functional materials; and laser marking, conductive additives, applications for counterfeit protection and high-quality cosmetic active ingredients. It views product innovation, acquisitions, research partnerships and broadening its portfolio of advanced memory and logic applications as its growth strategy.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops and produces prescription drugs. It markets pharmaceutical and biological prescription medicines with focus on conditions and diseases such as cancer, neurodegenerative diseases, infertility, cardiovascular diseases, and endocrine and metabolic disorders.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Operated by Sigma-Aldrich, which discovers and develops and manufactures diagnostics. Its product portfolio includes lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems to manufacture drugs. The segment provides lab materials, technologies and services to scientists and engineers. The segment is segregated further into three categories, namely, Research Solutions, Process Solutions and Applied Solutions. The Process Solutions category provides products and services for the entire pharmaceutical production value chain. The Research Solutions category offers products and services to promote life science research in biotechnology, pharmaceutical and academic research laboratories. The Applied Solutions category assists customers in their efforts to ensure that medicines, food and beverages are safe for consumption. The segment’s strategy is to focus on strengthening its core business by offering a broad portfolio and working for improvement in scientific areas such as cell and gene therapy and continuous bioprocessing.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer